Home > Insider Trading > Filing (0001209191-12-002549)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1292519	Invivo Therapeutics Holdings Corp.	NVIV	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503383	Francis Reynolds	C/O Invivo Therapeutics Holdings Corp. One Broadway, 14Th Floor Cambridge MA 02142	Ceo, Cfo	Yes	Yes	Yes	No

Transaction Summary

Sold:	250,000 shares	Avg. Price: $2.59	Total Value: $647,944.82
Number of Shares After Transactions:	14,647,660 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.00001 Par Value	Disposition	2012-01-04	44,497	$2.62	14,853,163	No	4	S	Direct
Common Stock, $0.00001 Par Value	Disposition	2012-01-05	109,000	$2.63	14,744,163	No	4	S	Direct
Common Stock, $0.00001 Par Value	Disposition	2012-01-06	96,503	$2.53	14,647,660	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	13,603	Indirect	By 401(k) Plan

Footnotes

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.60 to $2.70, inclusive. The reporting person undertakes to provide InVivo Therapeutics Holdings Corp. ("InVivo"), any security holder of InVivo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2 and 3 of this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.7035, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.60, inclusive.
Between October 1 and December 31, 2011, the reporting person acquired 13,603 shares of InVivo Therapeutics Holdings Corp. common stock under a 401(k) plan. The information in this report is based on a plan statement dated as of December 31, 2011.